Phase II Study of Neratinib in Older Adults with HER2 Amplified or HER2/3 Metastatic Breast Cancer

Journal Article
Written By Simran Padam

Journal of Geriatric Oncology

View publication ↗

DOWNLOAD PDF

Simran Padam
Previous

Characteristics Associated with Functional Changes During Systemic Cancer Treatments: A Systematic Review Focused on Older Adults
Next

Phase II Clinical Trial of Pembrolizumab and Enobosarm in Patients with Androgen Receptor-Positive Metastatic Triple-Negative Breast Cancer